CD274 and neoplasm: African American ethnicity and an aggressive cancer phenotype have been associated with prediction of tumor PD-L1 positivity in hormone-naïve tumors [98], suggesting a potential benefit for immunotherapy in African Americans at high risk of aggressive disease, but this has not been replicated yet [66].